These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis. Banks E; Canfell K Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078 [TBL] [Abstract][Full Text] [Related]
6. Health risks after cessation of postmenopausal hormone therapy. Pines A; Sturdee D; Birkhäuser M; Climacteric; 2008 Jun; 11(3):179-80. PubMed ID: 18568782 [No Abstract] [Full Text] [Related]
7. Postmenopausal hormone therapy and informed consent: a call for common sense. Kauffman RP; Castracane VD; Van Hook CL J Womens Health (Larchmt); 2005 Sep; 14(7):592-4. PubMed ID: 16181015 [No Abstract] [Full Text] [Related]
8. Variations on hormone replacement therapy: an answer to the 'one dose fits all' Women's Health Initiative study. Studd J Gynecol Endocrinol; 2007 Nov; 23(11):665-71. PubMed ID: 17943531 [TBL] [Abstract][Full Text] [Related]
9. Updating the EMAS 2004/2005 clinical recommendations on postmenopausal therapy following the recent publications: WHI and Nurses' Health Study. Gompel A; Barlow D; Rozenberg S; Skouby SO; Maturitas; 2006 Aug; 55(1):1-4. PubMed ID: 16678365 [TBL] [Abstract][Full Text] [Related]
10. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women. Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119 [TBL] [Abstract][Full Text] [Related]
11. The trials and tribulations of long-term postmenopausal hormone therapy. MacLennan AH Obstet Gynecol Surv; 2004 Feb; 59(2):65-7. PubMed ID: 14752298 [No Abstract] [Full Text] [Related]
12. Hormone therapy and cardiovascular disease in the early postmenopause: the WHI data revisited. Pines A; Sturdee DW; Birkhäuser MH; Climacteric; 2007 Jun; 10(3):195-6. PubMed ID: 17487646 [No Abstract] [Full Text] [Related]
13. Hormone therapy: gallbladder risk is lower with a patch than a pill. Harv Womens Health Watch; 2008 Oct; 16(2):6-7. PubMed ID: 19054848 [No Abstract] [Full Text] [Related]
14. [Optimal use of hormone replacement therapy for improving health in postmenopausal women]. Lin S Zhonghua Yi Xue Za Zhi; 2002 Dec; 82(23):1587-9. PubMed ID: 12703497 [No Abstract] [Full Text] [Related]
15. Updated practical recommendations for hormone replacement therapy in the peri- and postmenopause. Birkhäuser MH; Panay N; Archer DF; Barlow D; Burger H; Gambacciani M; Goldstein S; Pinkerton JA; Sturdee DW Climacteric; 2008 Apr; 11(2):108-23. PubMed ID: 18365854 [No Abstract] [Full Text] [Related]
16. [Prevention of coronary heart disease by early postmenopausal hormone therapy: new supporting data]. Gaspard U J Gynecol Obstet Biol Reprod (Paris); 2008 Jun; 37(4):340-5. PubMed ID: 18249506 [TBL] [Abstract][Full Text] [Related]
17. Continuous combined hormone replacement therapy relieves climacteric symptoms and improves health-related quality of life in early postmenopausal women. Pitkin J; Smetnik VP; Vadász P; Mustonen M; Salminen K; Ylikangas S; Menopause Int; 2007 Sep; 13(3):116-23. PubMed ID: 17785037 [TBL] [Abstract][Full Text] [Related]
18. Declines in breast cancer after the WHI: apparent impact of hormone therapy. Clarke CA; Glaser SL Cancer Causes Control; 2007 Oct; 18(8):847-52. PubMed ID: 17619153 [TBL] [Abstract][Full Text] [Related]